Highlights and Quick Summary
- Net Debt/EBITDA for the quarter ending June 30, 2023 was 0.0 (a -100.0% decrease compared to previous quarter)
- Year-over-year quarterly Net Debt/EBITDA decreased by NaN%
- Annual Net Debt/EBITDA for 2022 was 3.38 (a 5.18% increase from previous year)
- Annual Net Debt/EBITDA for 2022 was 3.22 (a 31.05% increase from previous year)
- Annual Net Debt/EBITDA for 2021 was 2.45 (a -206.06% decrease from previous year)
Visit stockrow.com/DRTS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Debt/EBITDA of Alpha Tau Medical Ltd.
Most recent Net Debt/EBITDAof DRTS including historical data for past 10 years.Interactive Chart of Net Debt/EBITDA of Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.0 | 10.88 | – | – | – |
| 2022 | 0.0 | 14.74 | 14.08 | 12.51 | 3.38 |
| 2021 | -5.59 | 0.2 | 0.32 | 0.46 | 2.45 |
| 2020 | – | – | -179.8 | 0.0 | 5.09 |
| 2019 | – | – | – | – | 0.0 |
Business Profile of Alpha Tau Medical Ltd.
Sector: Healthcare
Industry: Biotechnology